Just Earth News | @justearthnews | 04 May 2021, 01:20 am Print
Pfizer-BioNTech Image: Pixabay
Washinton/Sputnik: The US Food and Drug Administration (FDA) is preparing to approve the Pfizer-BioNTech COVID-19 vaccine for those aged 12 to 15, The New York Times reported, citing federal officials.
The authorization is expected to come early next week, the report said on Monday.
Pfizer announced several weeks ago that none of the adolescents who have received the vaccine during trials have contracted a symptomatic case of COVID-19.
However, plans to vaccinate teens and children, who rarely contract serious cases of the illness, have sparked debate, the report added, as many question whether excess US vaccines could be put to better use on adults in other countries.
- Doctor warns this everyday food habit could raise your colon cancer risk
- Long COVID harmed your brain's far more than you think. New study reveals its impact on Dopamine network
- Your phone could be damaging your bond with your teen, researchers warn parents
- Coffee lovers, rejoice! Study links daily coffee drinking to lower risk of liver cancer and cirrhosis
- Scientists develop one-hour oral cancer test that could end unnecessary painful biopsies
